The effect of coronary angiography and femoral access on femoral artery distensibility and elasticity
y | 08 mar 2021
Acerca de este artículo
Article Category: research-article
Publicado en línea: 08 mar 2021
Páginas: 48 - 52
Recibido: 02 jul 2020
Aceptado: 02 sept 2020
DOI: https://doi.org/10.15557/jou.2021.0007
Palabras clave
© 2021 Polish Ultrasound Society. Published by Medical Communications Sp. z o.o.
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Fig. 1.
Baseline clinic, demographic and laboratory values of the study population
| Group 1 ( |
Group 2 ( |
Group 3 ( |
Group 4 ( |
|
|
|---|---|---|---|---|---|
| Age [years] | 59.23 ± 5.62 | 60.7 ± 4.98 | 58.76 ± 5.66 | 59.61 ± 5.61 | 0.282 |
| Female sex [n (%)] | 23 (38.98) | 28 (49.12) | 21 (38.18) | 27 (45) | 0.598 |
| BMI [kg/m2] | 28.68 ± 3.56 | 28.73 ± 3.49 | 28.49 ± 3.18 | 28.71 ± 3.79 | 0.982 |
| Creatinine [mg/dL] | 0.78 ± 0.1 | 0.77 ± 0.11 | 0.79 ± 0.12 | 0.8 ± 0.13 | 0.577 |
| Hb [gr/dL] | 13.67 ± 1.29 | 13.76 ± 1.49 | 14.1±1.41 | 13.57 ± 1.41 | 0.2 |
| WBC [/mm3] | 7510 ± 1659 | 7212 ± 1923 | 7123 ± 1738 | 7309 ± 1887 | 0.614 |
| Platelets [100/mm3] | 280 (172) | 274 (56) | 245 (45) | 238 (81) | 0.075 |
| FPG [mg/dL] | 101.73 ± 9.87 | 102.16 ± 8.23 | 102.85 ± 10.26 | 102.53 ± 9.63 | 0.93 |
| HDL [mg/dL] | 45.47 ± 7.46 | 47.66 ± 9.05 | 47.36 ± 8.75 | 47.2 ± 6.97 | 0.457 |
| LDL [mg/dL] | 130.81 ± 16.35 | 135.1 ± 21.37 | 130.3 ± 16.73 | 132.21 ± 17.36 | 0.491 |
| Triglyceride [mg/dL] | 145 (88) | 134 (67) | 128 (79) | 147 (69) | 0.258 |
| EF [%] | 58.61 ± 2.91 | 58.78 ± 3.29 | 58.76 ± 2.97 | 59.08 ± 3.16 | 0.866 |
| SBP [mmHg] | 122.95 ± 6.8 | 124 ± 6.43 | 123.87 ± 9.12 | 122.82 ± 9.34 | 0.799 |
| DBP [mmHg] | 80.97 ± 5.45 | 81.04 ± 5.31 | 80.93 ± 5.83 | 81.60 ± 4.97 | 0.895 |
| USG time [month]* | 28 (16) | 29 (13.5) | 28 (14) | 27 (17.75) | 0.918 |
| SYNTAX Score | 7 (4) | 11 (6) | 15 (7) | 17 (5.75) | <0.001 |
| ASA [ |
33 (55.93) | 47 (82.45) | 48 (87.27) | 55 (91.66) | <0.001 |
| Beta blocker [ |
6 (10.16) | 27 (47.36) | 47 (85.45) | 55 (91.66) | <0.001 |
| Ca CB |
6 (10.16) | 6 (10.52) | 6 (10.9) | 5 (8.3) | 0.968 |
| Trimetazidine |
0 (0) | 0 (0) | 0 (0) | 12 (20) | NA |
| Nitrates [ |
0 (0) | 0 (0) | 11 (21.81) | 51 (85) | NA |
| Ranolazine |
0 (0) | 0 (0) | 6 (10.9) | 17 (28.33) | NA |
Comparison of femoral distensibility and elasticity between the sides with and without femoral access in different groups
| Group 1 ( |
Group 2 ( |
Group 3 ( |
Group 4 ( |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Access side | No access side |
|
Access side | No access side |
|
Access side | No access side |
|
Access side | No access side |
|
|
| Distensibility [%] | 9.40 ± 0.84 | 9.48 ± 0.75 | 0.107 | 9.02 ± 0.81 | 9.23 ± 0.75 | <0.001 | 8.49 ± 0.77 | 9.18 ± 0.9 | <0.001 | 8.14 ± 0.74 | 9.03 ± 0.81 | <0.001 |
| Elasticity [%/mmHg] | 0.23 ± 0.03 | 0.23 ± 0.03 | 0.433 | 0.21 ± 0.02 | 0.22 ± 0.02 | <0.001 | 0.19 ± 0.02 | 0.21 ± 0.02 | <0.001 | 0.16 ± 0.01 | 0.2 ± 0.02 | <0.001 |